Gene · 392
Papers1,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Critical Roles of Circular RNA in Tumor Metastasis via Acting as a Sponge of miRNA/isomiR. | Int J Mol Sci | 2022 | 35806027 | PubTator, text mining | PubMed |
| Endocrine and behavioural features of Lowe syndrome and their potential molecular mechanisms. | J Med Genet | 2022 | 35803701 | PubTator, text mining | PubMed |
| Surgical treatment and muscle protein analysis of V-pattern exotropia in craniosynostosis. | Sci Rep | 2022 | 35798790 | PubTator, text mining | PubMed |
| The E3 ligase Thin controls homeostatic plasticity through neurotransmitter release repression. | Elife | 2022 | 35796533 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs have a significant effect on tumor metastasis. | Mol Ther Nucleic Acids | 2022 | 35784014 | PubTator, text mining | PubMed |
| Proteomics-based investigation of cerebrovascular molecular mechanisms in cerebral amyloid angiopathy by the FFPE-LMD-PCT-SWATH method. | Fluids Barriers CNS | 2022 | 35778717 | PubTator, text mining | PubMed |
| A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome. | Diabetologia | 2022 | 35771237 | PubTator, text mining | PubMed |
| Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma. | Front Oncol | 2022 | 35769708 | PubTator, text mining | PubMed |
| Whole transcriptome expression array analysis of human colon fibroblasts culture treated with Helichrysum italicum supports its use in traditional medicine. | J Ethnopharmacol | 2022 | 35764197 | PubTator, text mining | PubMed |
| Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial. | Clin Cancer Res | 2022 | 35763041 | PubTator, text mining | PubMed |
| Rho GTPase-activating protein 35 suppresses gastric cancer metastasis by regulating cytoskeleton reorganization and epithelial-to-mesenchymal transition. | Bioengineered | 2022 | 35758029 | PubTator, text mining | PubMed |
| Arap1 loss causes retinal pigment epithelium phagocytic dysfunction and subsequent photoreceptor death. | Dis Model Mech | 2022 | 35758026 | PubTator, text mining | PubMed |
| miRNA-Gene Interaction Network Construction Strategy to Discern Promising Traditional Chinese Medicine against Osteoporosis. | Biomed Res Int | 2022 | 35757478 | PubTator, text mining | PubMed |
| Laminin-511 Activates the Human Induced Pluripotent Stem Cell Survival via α6β1 Integrin-Fyn-RhoA-ROCK Signaling. | Stem Cells Dev | 2022 | 35726387 | PubTator, text mining | PubMed |
| Neurodevelopmental disorders, immunity, and cancer are connected. | iScience | 2022 | 35712080 | PubTator, text mining | PubMed |
| Dynamic Meta-data Network Sparse PCA for Cancer Subtype Biomarker Screening. | Front Genet | 2022 | 35711917 | PubTator, text mining | PubMed |
| Genome-wide translation control analysis of developing human neurons. | Mol Brain | 2022 | 35706057 | PubTator, text mining | PubMed |
| DEPDC1B collaborates with GABRD to regulate ESCC progression. | Cancer Cell Int | 2022 | 35706026 | PubTator, text mining | PubMed |
| The complex of Fas-associated factor 1 with Hsp70 stabilizes the adherens junction integrity by suppressing RhoA activation. | J Mol Cell Biol | 2022 | 35704671 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/392/papers?page=13